Results 21 to 30 of about 9,067 (180)

Cell Viability Assays for Candida auris [PDF]

, 2022
Cell viability assays are useful for assessing the efficacy of antifungal therapeutics and disinfection strategies in vitro. In recent years these assays have been fundamental for the testing of conventional and novel therapies against the nosocomial fungal pathogen Candida auris.
Brown, Jason L., Short, Bryn, Ware, Alicia, Sherry, Leighann, Kean, Ryan, Ramage, Gordon   +5 more
openaire   +2 more sources

Comparison of Two Commercially Available qPCR Kits for the Detection of Candida auris

Journal of Fungi, 2021
Candida auris is an emerging pathogen with resistance to many commonly used antifungal agents. Infections with C. auris require rapid and reliable detection methods to initiate successful medical treatment and contain hospital outbreaks.
Janko Sattler, Janina Noster, Anne Brunke, Georg Plum, Pia Wiegel, Oliver Kurzai, Jacques F. Meis, Axel Hamprecht   +7 more
doaj   +1 more source

Candida auris in Dog Ears

Journal of Fungi, 2023
Candida auris is an emerging global public health threat and is resistant to most antifungal agents. Though fungi are significant pathogens for animals, the role of C. auris in animal health remains unexplored. Here, we analysed the microbial cultures of skin and ear swabs of 87 dogs in Delhi and performed fungal meta-barcode sequencing of ear and skin
Anamika Yadav, Yue Wang, Kusum Jain, Vijay Amrit Raj Panwar, Hardeep Kaur, Vikas Kasana, Jianping Xu, Anuradha Chowdhary   +7 more
openaire   +3 more sources

Persistent candidemia despite appropriate fungal therapy: First case of Candida auris from the United Arab Emirates

International Journal of Infectious Diseases, 2018
In this case, we report an elderly patient with multiple chronic conditions and prolonged intensive care unit (ICU) stays who had recurrent Candida auris (C. auris) in blood despite antifungal therapy. C.
Adnan Alatoom, Mohammad Sartawi, Karen Lawlor, Laila AbdelWareth, Jens Thomsen, Ahmad Nusair, Imran Mirza   +6 more
doaj   +1 more source

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections

Antibiotics, 2020
Candida auris is an emerging multidrug-resistant fungal pathogen reported worldwide. Infections due to C. auris are usually nosocomial and associated with high rates of fluconazole resistance and mortality.
Mahmoud Ghannoum, Maiken Cavling Arendrup, Vishnu P. Chaturvedi, Shawn R. Lockhart, Thomas S. McCormick, Sudha Chaturvedi, Elizabeth L. Berkow, Deven Juneja, Bansidhar Tarai, Nkechi Azie, David Angulo, Thomas J. Walsh   +11 more
doaj   +1 more source

Emergence of multidrug-resistant and opportunistic fungal infections due to Candida auris in intensive care units [PDF]

Current Medical Mycology
Background and Purpose: An increasing number of invasive infections due to multidrug-resistant Candida species have been reported worldwide. Among these Candida species, Candida auris has attracted more attention in recent years due to major outbreaks in
Peetam Singh, Anita Pandey
doaj   +1 more source

Conserved Role for Biofilm Matrix Polysaccharides in Candida auris Drug Resistance

mSphere, 2019
Candida auris has emerged as an outbreak pathogen associated with high mortality. Biofilm formation and linked drug resistance are common among Candida species. Drug sequestration by the biofilm matrix accounts for much of the antifungal tolerance.
E. G. Dominguez, R. Zarnowski, H. L. Choy, M. Zhao, H. Sanchez, Jeniel E. Nett, D. R. Andes   +6 more
doaj   +1 more source

Different efficacies of common disinfection methods against candida auris and other candida species

Journal of Infection and Public Health, 2020
Background: Candida auris can form long-lasting colonies in the hospital environment and on human skin. There is limited evidence regarding the efficacy of different methods and products for disinfecting hospitals and colonized patients to prevent the ...
Leiwen Fu, Tingting Le, Zhihua Liu, Ling Wang, Huijie Guo, Jun Yang, Qing Chen, Jing Hu   +7 more
doaj   +1 more source

Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer

Frontiers in Cellular and Infection Microbiology, 2021
The occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings.
Elena De Carolis, Federica Marchionni, Marilisa La Rosa, Jacques F. Meis, Jacques F. Meis, Anuradha Chowdhary, Brunella Posteraro, Maurizio Sanguinetti, Maurizio Sanguinetti   +8 more
doaj   +1 more source

Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan?

Journal of the Formosan Medical Association, 2018
Candida auris is a recently identified multi-resistant Candida species, first reported in Japan in 2009, and poses a serious global health threat. Lack of awareness of this new Candida species and difficulties with laboratory identification have impacted
Po-Liang Lu, Wei-Lun Liu, Hsiu-Jung Lo, Fu-Der Wang, Wen-Chien Ko, Po-Ren Hsueh, Mao-Wang Ho, Chun-Eng Liu, Yen-Hsu Chen, Yee-Chun Chen, Yin-Ching Chuang, Shan-Chwen Chang   +11 more
doaj   +1 more source